Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Acta Neurochir (Wien). 2012 Jun;154(6):1003-10. doi: 10.1007/s00701-012-1339-8. Epub 2012 Apr 11.
To determine the prognostic factors for the incidence and the outcome of seizure in patients with cerebral arteriovenous malformation (AVM) and to identify the time to seizure-free state according to the treatment modalities.
Between 1995 and 2008, the multidisciplinary team at our institution treated 399 patients with cerebral AVMs. Treatment consisted of surgical resection, radiosurgery, and embolization, either alone or in combination. The median follow-up period was 6.0 years (range, 3.0-16.2 years). Eighty-six patients (21.5 %) experienced seizures before treatment. We investigated the variables associated with seizure incidence and seizure outcome and analyzed the outcomes of seizure among each treatment modality.
After treatment, 60 (70 %) patients were seizure-free. Compared with 313 patients who did not experience seizures, we found that younger age (≤ 35 years), size ≥ 3 cm, and location of temporal lobe were associated with seizures (p < 0.05). Short seizure history, accompanying intracerebral hemorrhage, generalized tonic-clonic type seizure, deep-seated or infratentorial AVM, complete obliteration of AVM, and a favorable neurological outcome at 12 months were closely associated with Engel Class I outcomes (p < 0.05). Seizure-free outcomes after microsurgery, radiosurgery, or embolization were 78 %, 66 %, and 50 %, respectively. The overall annual bleeding rate was 1.0 % and 2.2 % in microsurgery-treated and radiosurgery-treated AVMs, respectively. In the surgery group, the median time to seizure-free status was 1.1 months (95 % CI, 0.7-1.2 months), whereas the radiosurgery group and embolization-alone group showed 20.5 months (95 % CI, 18.3-23.8 months), and 8.1 months (95 % CI, 6.0-13.5 months), respectively.
A multidisciplinary team approach for cerebral AVMs achieved satisfactory seizure control results. Microsurgery led to the highest percentage of seizure-free outcomes and had the lowest annual bleeding rate, whereas radiosurgery had a higher bleeding rate. Median time to seizure-free status in surgically treated patients was shorter than in patients who underwent radiosurgical or endovascular treatment.
为了确定脑动静脉畸形(AVM)患者发生癫痫的预后因素和癫痫结局,并根据治疗方式确定达到无癫痫状态的时间。
在 1995 年至 2008 年期间,我们机构的多学科团队治疗了 399 例脑 AVM 患者。治疗包括单独或联合应用手术切除、放射外科和栓塞。中位随访时间为 6.0 年(范围,3.0-16.2 年)。86 例患者(21.5%)在治疗前有癫痫发作。我们调查了与癫痫发作发生率和癫痫结局相关的变量,并分析了每种治疗方式的癫痫结局。
治疗后,60 例(70%)患者无癫痫发作。与 313 例未发生癫痫的患者相比,我们发现年龄较小(≤35 岁)、病灶较大(≥3cm)和颞叶位置与癫痫发作相关(p<0.05)。癫痫病史较短、伴发颅内出血、全面性强直阵挛发作、病灶位于深部或幕下、AVM 完全闭塞、12 个月时神经功能预后良好与 Engel Ⅰ级结局密切相关(p<0.05)。显微镜手术、放射外科或栓塞治疗后的无癫痫发作结局分别为 78%、66%和 50%。显微镜手术治疗和放射外科治疗的 AVM 年出血率分别为 1.0%和 2.2%。在手术组中,达到无癫痫状态的中位时间为 1.1 个月(95%CI,0.7-1.2 个月),而放射外科组和单独栓塞组分别为 20.5 个月(95%CI,18.3-23.8 个月)和 8.1 个月(95%CI,6.0-13.5 个月)。
脑 AVM 的多学科治疗方法取得了令人满意的癫痫控制效果。显微镜手术导致的无癫痫发作比例最高,年出血率最低,而放射外科的出血率较高。手术治疗患者达到无癫痫状态的中位时间短于接受放射外科或血管内治疗的患者。